Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

107

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

107 results for “Drug exposure”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov32/100

Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men

ClinicalTrials.gov study NCT04593680. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

ClinicalTrials.gov study NCT05824988. IPD Sharing: NO. Countries: 1. Publications: 11.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women

ClinicalTrials.gov study NCT04590417. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
dryad32/100

Data from: Risks of 23 specific malformations associated with prenatal exposure to ten antiepileptic drugs

Open the record for dataset details and reuse information.

publicJun 2019View details →
dryad28/100

Data from: Evaluation of exposure to effervescent drugs in a large health check-up population in France: a cross-sectional study

OBJECTIVES: The relationship between high dietary sodium intake and hypertension is well established. Some drugs are associated with high-sodium content, particularly effervescent tablets (ETs). Despite a possible cardiovascular risk associated with the use of such drugs, observational data describing exposure to ETs in ambulatory subjects are lacking. The aim of this study was to estimate the prevalence of exposure to ETs, and to highlight factors associated with this exposure, in a large French health check-up population. DESIGN: This was cross-sectional study. SETTING AND PARTICIPANTS: Participants were French individuals who underwent medical check-ups at the Investigations Préventives et Cliniques center between April and June 2017. RESULTS: In total, 1,043 subjects were included in the study. The prevalence of exposure to ETs in the last 30 days was 26.9% (95% CI: 24.2 – 29.6). Exposure was frequent (i.e. two ETs per week or more in the last 30 days) for 7.3% of subjects. Self-medication was the major source of exposure (93.8%). Paracetamol, aspirin, vitamins, and betaine accounted for 95.3% of the ETs used. The factors associated with this exposure by multivariate analysis were: male gender, Overseas French origin, depression and body mass index ≥ 25 kg.m-2. A diagnosis of hypertension or treatment with diuretics were not protective factors against exposure to ETs. CONCLUSION: Exposure to ETs is frequent in the general population, particularly through self-medication. Clinical conditions associated with low-salt requirements were not associated with lower exposure to ETs, suggesting a lack of awareness by practitioners and patients about this iatrogenic issue.

opencc-zeroDec 2017View details →
dryad28/100

Data from: Exposure to phages has little impact on the evolution of bacterial antibiotic resistance on drug concentration gradients

The use of phages for treating bacterial pathogens has recently been advocated as an alternative to antibiotic therapy. Here we test a hypothesis that bacteria treated with phages may show more limited evolution of antibiotic resistance as the fitness costs of resistance to phages may add to those of antibiotic resistance, further reducing the growth performance of antibiotic-resistant bacteria. We did this by studying the evolution of phage-exposed and phage-free Pseudomonas fluorescens cultures on concentration gradients of single drugs, including cefotaxime, chloramphenicol, and kanamycin. During drug treatment, the level of bacterial antibiotic resistance increased through time, and was not affected by the phage treatment. Exposure to phages did not cause slower growth in antibiotic-resistant bacteria, although it did so in antibiotic-susceptible bacteria. We observed significant reversion of antibiotic resistance after drug use being terminated, and the rate of reversion was not affected by the phage treatment. The results suggest that the fitness costs caused by resistance to phages are unlikely to be an important constraint on the evolution of bacterial antibiotic resistance in heterogeneous drug environments. Further studies are needed for the interaction of fitness costs of antibiotic resistance with other factors.

opencc-zeroDec 2012View details →
ClinicalTrials.gov28/100

Relative Drug Exposures Of Two Formulations of PF-02341066

ClinicalTrials.gov study NCT00939731. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects

ClinicalTrials.gov study NCT01461824. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Drug Exposure Feedback and Education for Nurses' Safety

ClinicalTrials.gov study NCT02283164. IPD Sharing: Not stated. Countries: 0. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

ClinicalTrials.gov study NCT07199335. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

A Study Comparing the Drug Exposure in Humans After Administration of a 50 mg Tablet of Sertraline Hydrochloride as Compared to a 50 mg Capsule of Sertraline Hydrochloride Under Fasted (Nonfed) Condit

ClinicalTrials.gov study NCT01235195. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
dryad28/100

Data from: Evaluation of exposure to effervescent drugs in a large health check-up population in France: a cross-sectional study

Open the record for dataset details and reuse information.

publicJun 2018View details →
dryad28/100

Data from: Exposure to phages has little impact on the evolution of bacterial antibiotic resistance on drug concentration gradients

Open the record for dataset details and reuse information.

publicNov 2013View details →
geo24/100

Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [ATAC-Seq]

GEO Series GSE100750. Homo sapiens. 18 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenJul 2017View details →
geo24/100

Drug intervention of radiation exposure induced BBB injury via mitochondria-mediated non-infectious inflammation

GEO Series GSE280304. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenSep 2025View details →
geo24/100

Gene expression profiles of HMEC-1 after exposure to the chemotherapeutic drugs bleomycin and cisplatin with untreated samples as control

GEO Series GSE62523. Homo sapiens. 104 samples. Type: Expression profiling by array.

openGEO-OpenOct 2014View details →
geo24/100

Exposure to the antiretroviral drug dolutegravir impairs structure and neurogenesis in a forebrain organoid model of human embryonic cortical development

GEO Series GSE275931. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenSep 2024View details →
geo24/100

Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq]

GEO Series GSE100751. Homo sapiens. 18 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJul 2017View details →
geo24/100

Gene expression changes in SHI-1 cells following exposure to disulfiram/copper, niclosamde or combined drugs

GEO Series GSE262673. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJul 2024View details →
geo24/100

Drug-tolerant cancer cell persisters survive lethal exposures by silencing transposable elements [ChIP-Seq]

GEO Series GSE74179. Homo sapiens. 8 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenJul 2017View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record